Protective antibodies persist for months in survivors of serious COVID-19 infections People who survive serious COVID-19 infections have long-lasting immune responses against the virus, according to a new study led by researchers at Massachusetts General Hospital (MGH). The study, published in Science Immunology, ... Oct 8, 2020 0 93
Novel digital dashboard improves cancer case review efficiency Multidisciplinary tumor boards are vital to cancer treatment plans, bringing together clinicians from different specialties to guide patient treatment and improve outcomes. However, compiling the relevant data for each case ... Oct 8, 2020 0 3
Revised clinical trial rules during COVID-19 pandemic may benefit patients, survey shows The COVID-19 pandemic has led to new rules and expectations for clinical trials. Following guidance from federal agencies, institutions such as UT Southwestern adjusted clinical trial operations. To protect patient safety, ... Oct 8, 2020 0 1
Early COVID-19 cases in Southern California linked to New York Most COVID-19 (coronavirus) patients in Southern California during the early months of the pandemic appear to have been infected by a variant of the SARS-CoV-2 virus introduced to the region from New York state via Europe, ... Oct 8, 2020 0 33
Severe COVID-19 infection linked to overactive immune cells Samples from the lungs of patients show a runaway immune system reaction could be one mechanism behind severe COVID-19 cases. Oct 8, 2020 0 56
Understanding the progress of viral infections It is only 120 millionths of a millimeter in size but can bring entire countries to a standstill: the Corona virus. Even if it were to disappear one day, viral infections will still be among the most frequent and difficult-to-treat ... Oct 8, 2020 0 1
Six states set records for COVID-19 hospitalizations (HealthDay)—Records for COVID-19 hospitalizations were set Tuesday in six states—Arkansas, Montana, North Dakota, South Dakota, Wisconsin, and Wyoming. Oct 8, 2020 0 1
Novel radioimmunotherapy reverses resistance to commonly used lymphoma drug A new radioimmunotherapy has proven effective in reversing resistance to the most commonly used lymphoma drug, rituximab, according to research published in the October issue of The Journal of Nuclear Medicine. When used ... Oct 8, 2020 0 2
'Danger molecule' associated with being obese, female and black in younger adults A 'danger molecule' is higher in the blood of younger black adults than whites, females than males and increases with weight and age, researchers report in the first large, longitudinal study associating circulating HMGB1 ... Oct 8, 2020 0 10
Blocking immune system pathway may stop COVID-19 infection, prevent severe organ damage While the world waits eagerly for a safe and effective vaccine to prevent infections from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus behind the COVID-19 pandemic, researchers also are focusing ... Oct 8, 2020 0 88